Reach Us +447480022765
Role Of Inflammatory Biomarkers In Chronic Obstructive Pulmonary Disease | 48676
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Role of inflammatory biomarkers in chronic obstructive pulmonary disease

4th International Conference and Exhibition on Lung & Respiratory Care

Ola Alkady

Sohag University, Egypt

Posters & Accepted Abstracts: J Pulm Respir Med

DOI: 10.4172/2161-105X.C1.014

Purpose: Chronic obstructive pulmonary disease (COPD) is a multicomponent disease. There is a need for biological markers for better evaluation of patients with COPD. We tested the hypothesis that elevated levels of inflammatory biomarkers fibrinogen, C-reactive protein (CRP) and leukocyte count (WBC) in individuals with stable COPD are associated with an increased risk of exacerbation. Patients and methods: Ninety-eight COPD patients diagnosed and classified as COPD and 30 age and gender matched healthy subjects with normal pulmonary function were observed. Patient follow-up was performed to evaluate the strength of the associations between inflammatory biomarker levels and future outcome. Results: Inflammatory biomarkers increase with exacerbation compared to the remission state, mean WBC, CRP and fibrinogen at 12.212×109/L, 39.462 mg/L and 5.09 g/L in exacerbation respectively compared to 7.877×109/L, 4.142 mg/L and 2.299 g/L in remission with P values <0.001, <0.001 and <0.004, respectively. Statistically significant correlation was noticed between the levels of fibrinogen and the % predicted FEV1 (r=0.209, P=0.038) however CRP and WBC did not correlate with % predicted FEV1 (r=_0.031, P=0.765) for CRP, and that for WBC (r=0.125, P=0.221). Conclusion: Elevated levels of CRP, fibrinogen and leukocyte count in individuals with COPD were associated with increased exacerbation risk. Clinical Implications: Inflammatory biomarkers hold promise for improving the understanding of the complex mechanisms propagating COPD exacerbation. Fibrinogen in particular has emerged as a potentially useful biomarker and requires further investigation.

Ola Alkady completed education at Sohag University in Egypt. Currently researching on Chronic obstructive pulmonary disease (COPD) is a multicomponent disease.

Email: [email protected]